Dr Reddys Laboratories
Prakash Diwan, Chief Portfolio Strategist, Prakash Diwan's Wealth Circle, ECR told CNBC-TV18, "This is the beginning of a very strong momentum in Dr Reddys Laboratories . If one looks at the changes in the management which they have announced recently are people who actually hold a lot of promising potential in terms of taking the company forward. The company's pipeline also is significantly stronger."
Rajesh Agarwal, Head of Research, Eastern Financiers Limited told CNBC-TV18, "Both Oil India and Tata Steel are very good stocks for ones portfolio and it has to be ones own choice. With subsidy burden going down I think it is going to be a big positive for companies like Oil India, Oil and Natural Gas Corporation (ONGC) because diesel prices have been hiked month on month basis. The government nod for exploration for KG-D6 basin gas received would also be a big positive trigger."
Rajesh Agarwal, Head of Research, Eastern Financiers Limited told CNBC-TV18, "In auto space we have two top picks, one is Tata Motors and in two-wheeler we have Bajaj Auto as our top pick. As far as Tata Motors is concerned although domestic sales have been very sluggish in the last few months but if you look at JLR the numbers have been very encouraging. Even today the 12 percent growth number which they have announced despite all the slowdown in European markets and Chinese markets it is very encouraging. Going forward also we believe that this performance is going to be repeated."
Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "This market is choppy so while theNifty and big components are moving down and likely to do so there are individual winners. So, I am preferring to stay with the broad trend and go long. Buy Sun Pharma , that is an outperforming stock, no problems at all. It went through a minor correction and it is now looking up. I think that upside momentum will continue."
DISCLAIMER: GoodReturns provides you with information covering shares, futures and options based on broker's reports as stated on various media. Investors are, however, warned that they should NOT take any buy or sell decision based on these views expressed in the article. Investors should consult their own financial and share advisors before taking purchase or sale decisions. GoodReturns does not take any responsibility for any losses incurred by investors who take their cues from the above article.